IGF2BP1 and head and neck squamous cell carcinoma: High expression of insulin growth factor 2 mRNA binding protein 1 (IGF2BP1) is associated with a poor prognosis such as advanced clinical stage, increased tumor size, lymph node metastasis, and low survival rate of patients with HNSCC (69, 70).